Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

Historical Holders from Q3 2022 to Q2 2025

Symbol
SYRS on OTC
CUSIP
87184Q206
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
27.2M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-4
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avidity Partners Management LP 7.6% $41K 2.05M Avidity Partners Management LP Dec 31, 2024
Samsara BioCapital, L.P. 2.6% $14.1K 707K Samsara BioCapital, L.P. Nov 18, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.98% $10.6K 532K Adage Capital Management, L.P. Dec 31, 2024
Point72 Asset Management, L.P. 0% $9.92 496 Point72 Asset Management, L.P. Dec 31, 2024

Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$12.4K 0
2025 Q1 463K $12.4K -$1.11M $0.03 4
2024 Q4 5.22M $1.2M -$30M $0.23 41
2024 Q3 18.9M $40.7M -$19.6M $2.15 67
2024 Q2 20.4M $105M -$2.84M $5.16 70
2024 Q1 20.9M $112M +$14.5M $5.35 76
2023 Q4 17.8M $138M +$54M $7.79 56
2023 Q3 12.1M $47.9M +$6.04M $3.95 48
2023 Q2 10.6M $33.5M +$1.18M $3.15 52
2023 Q1 10.3M $27.5M -$1.43M $2.67 52
2022 Q4 10.6M $37.9M +$7.58M $3.59 51
2022 Q3 8.18M $52.7M +$52.7M $6.44 38